1,289 reports of this reaction
1.4% of all HYDROCODONE BITARTRATE reports
#9 most reported adverse reaction
DRUG WITHDRAWAL SYNDROME NEONATAL is the #9 most commonly reported adverse reaction for HYDROCODONE BITARTRATE, manufactured by Purdue Pharma LP. There are 1,289 FDA adverse event reports linking HYDROCODONE BITARTRATE to DRUG WITHDRAWAL SYNDROME NEONATAL. This represents approximately 1.4% of all 89,079 adverse event reports for this drug.
Patients taking HYDROCODONE BITARTRATE who experience drug withdrawal syndrome neonatal should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG WITHDRAWAL SYNDROME NEONATAL is a less commonly reported adverse event for HYDROCODONE BITARTRATE, but still significant enough to appear in the safety profile.
In addition to drug withdrawal syndrome neonatal, the following adverse reactions have been reported for HYDROCODONE BITARTRATE:
The following drugs have also been linked to drug withdrawal syndrome neonatal in FDA adverse event reports:
DRUG WITHDRAWAL SYNDROME NEONATAL has been reported as an adverse event in 1,289 FDA reports for HYDROCODONE BITARTRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG WITHDRAWAL SYNDROME NEONATAL accounts for approximately 1.4% of all adverse event reports for HYDROCODONE BITARTRATE, making it a notable side effect.
If you experience drug withdrawal syndrome neonatal while taking HYDROCODONE BITARTRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.